| For: | Liu LJ, Xie SX, Chen YT, Xue JL, Zhang CJ, Zhu F. Aberrant regulation of Wnt signaling in hepatocellular carcinoma. World J Gastroenterol 2016; 22(33): 7486-7499 [PMID: 27672271 DOI: 10.3748/wjg.v22.i33.7486] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i33/7486.htm |
| Number | Citing Articles |
| 1 |
S Mahmoud A Najafi. The Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy. Iranian Biomedical Journal 2020; 24(5) doi: 10.29252/ibj.24.5.264
|
| 2 |
Kaushik Neogi, Prashant R. Murumkar, Priyanshu Sharma, Poonam Yadav, Mallika Tewari, Devarajan Karunagaran, Prasanta Kumar Nayak, Mange Ram Yadav. Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway. Translational Oncology 2022; 19 doi: 10.1016/j.tranon.2022.101395
|
| 3 |
Nafiseh Chalabi Hagkarim, Roger J. Grand. Tankyrases and Their Binding Proteins: Origins of Their Roles in Diverse Cellular Pathways. Cells 2026; 15(4) doi: 10.3390/cells15040348
|
| 4 |
Monisha Prasad, Silambarasan Tamil Selvan, Rajeshkumar Shanmugam, Ramadurai Murugan, Mohammad Fareed. Analysing the Anticancer Properties of Pterostilbene Through Absorption, Distribution, Metabolism, and Excretion (ADME) and Molecular Docking Studies. Cureus 2024; doi: 10.7759/cureus.58425
|
| 5 |
LILIANA PASLARU, PETRUTA ALEXANDRU, SANDA M. CRETOIU, SIMONA O. DIMA, IRINEL POPESCU. CRISPR/Cas9 gene editing in Huh7 and Hepa RG cell lines. Romanian Biotechnological Letters 2019; 24(2) doi: 10.25083/rbl/24.2/216.228
|
| 6 |
Anastasia Chambers, Morgan Reeves, Abhishek Shrestha, Siri Yarrapatni, Sergio Duarte, Ali Zarrinpar. β-Catenin Signaling in Hepatocellular Carcinoma: Mechanisms of Therapeutic Resistance and Emerging Therapeutic Strategies. Current Oncology 2026; 33(10) doi: 10.3390/curroncol33100576
|
| 7 |
Yinkai Xu, Daoming Shen, Jianxia Liu, Xiaolan Xu, Junhao Tu, Lei Qin, Liyang Jiang, Haixin Qian, Fengbao Guo. Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma. Journal of Molecular Histology 2020; 51(6) doi: 10.1007/s10735-020-09912-6
|
| 8 |
Chen Xue, Qingfei Chu, Qingmiao Shi, Yifan Zeng, Juan Lu, Lanjuan Li. Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02142-w
|
| 9 |
Mahir Azmal, Jibon Kumar Paul, Omar Faruk Talukder, ANM Shah Newaz Been Haque, Ajit Ghosh. Computational identification of phytochemicals as glycogen synthase kinase 3 beta (GSK3β) inhibitors for therapeutic applications in chronic diseases. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-17343-0
|
| 10 |
Li-Juan Liu, Jian-Ming Liao, Fan Zhu. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors. World Journal of Gastrointestinal Oncology 2021; 13(10): 1425-1439 doi: 10.4251/wjgo.v13.i10.1425
|
| 11 |
Wanhu Fan, Fenjing Du, Xiaojing Liu. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling. European Journal of Pharmacology 2019; 850 doi: 10.1016/j.ejphar.2019.01.054
|
| 12 |
Yuxia Li, Ruijiao Lu, Xieyidai Abuduhailili, Yangchun Feng. Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2025; doi: 10.2147/JHC.S504078
|
| 13 |
Silvia Zappavigna, Alessia Maria Cossu, Anna Grimaldi, Marco Bocchetti, Giuseppe Andrea Ferraro, Giovanni Francesco Nicoletti, Rosanna Filosa, Michele Caraglia. Anti-Inflammatory Drugs as Anticancer Agents. International Journal of Molecular Sciences 2020; 21(7) doi: 10.3390/ijms21072605
|
| 14 |
Hiroyasu Sakai, Yasuhiro Yamada, Masaya Kubota, Kenji Imai, Yohei Shirakami, Hiroyuki Tomita, Akira Hara, Masahito Shimizu. The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway. Carcinogenesis 2022; 43(3) doi: 10.1093/carcin/bgab099
|
| 15 |
Norihiko Yamamoto, Akiko Eguchi, Yoshifumi Hirokawa, Suguru Ogura, Kazushi Sugimoto, Motoh Iwasa, Masatoshi Watanabe, Yoshiyuki Takei. Expression Pattern of Plexin Domain Containing 2 in Human Hepatocellular Carcinoma. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy 2020; 39(2) doi: 10.1089/mab.2019.0050
|
| 16 |
Dimitrios N Samonakis, Elias A Kouroumalis. Systemic treatment for hepatocellular carcinoma: Still unmet expectations. World Journal of Hepatology 2017; 9(2): 80-90 doi: 10.4254/wjh.v9.i2.80
|
| 17 |
Kaushik Neogi, Mallika Tewari, Ashish Kumar Singh, Kavyanjali Sharma, Gullanki Naga Venkata Charan Tej, Sumit Singh Verma, Subash Chandra Gupta, Prasanta Kumar Nayak. Transcription factor 4 expression and correlation with tumor progression in gallbladder cancer. Journal of Cancer Research and Therapeutics 2022; 18(3) doi: 10.4103/jcrt.jcrt_1381_21
|
| 18 |
Fei Cao, Li-Xue Yin. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Experimental and Molecular Pathology 2019; 106 doi: 10.1016/j.yexmp.2018.10.009
|
| 19 |
Małgorzata Guz, Witold Jeleniewicz, Marek Cybulski. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031234
|
| 20 |
William P. Harris, Kit Man Wong, Supriya Saha, Imane El Dika, Ghassan K. Abou-Alfa. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers. Seminars in Oncology 2018; 45(3) doi: 10.1053/j.seminoncol.2018.03.002
|
| 21 |
Juan Bayo, Esteban J. Fiore, Luciana M. Dominguez, Alejandrina Real, Mariana Malvicini, Manglio Rizzo, Catalina Atorrasagasti, Mariana G. García, Josepmaria Argemi, Elisabeth D. Martinez, Guillermo D. Mazzolini. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. Journal of Hepatology 2019; 71(1) doi: 10.1016/j.jhep.2019.03.007
|
| 22 |
Sara Hooshmand, Mohammad Reza Mahdinezhad, Shirin Taraz Jamshidi, Mohammad Soukhtanloo, Farshad Mirzavi, Mehrdad Iranshahi, Maedeh Hasanpour, Ahmad Ghorbani. Morus nigra L. extract prolongs survival of rats with hepatocellular carcinoma. Phytotherapy Research 2021; 35(6) doi: 10.1002/ptr.7056
|
| 23 |
Xiaoyun Hu, Guosheng Yuan, Qi Li, Jing Huang, Xiao Cheng, Jinzhang Chen. DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway. Annals of Medicine 2021; 53(1) doi: 10.1080/07853890.2021.1898674
|
| 24 |
Sebastian Winkler, Ivana Winkler, Mirjam Figaschewski, Thorsten Tiede, Alfred Nordheim, Oliver Kohlbacher. De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-04670-6
|
| 25 |
Shijing Yu, Ruirui Zhao, Bingchen Zhang, Chunmei Lai, Linyan Li, Jiangwen Shen, Xiarong Tan, Jingwei Shao. Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma. Asian Journal of Pharmaceutical Sciences 2023; 18(4) doi: 10.1016/j.ajps.2023.100828
|
| 26 |
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen. Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 2022; 34(24) doi: 10.1002/adma.202109210
|
| 27 |
Danping Huang, Bowen Yang, Yaoyao Yao, Mianmian Liao, Yu Zhang, Yihao Zeng, Fengxue Zhang, Neng Wang, Guangdong Tong. Autophagic Inhibition of Caveolin-1 by Compound Phyllanthus urinaria L. Activates Ubiquitination and Proteasome Degradation of β-catenin to Suppress Metastasis of Hepatitis B-Associated Hepatocellular Carcinoma. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.659325
|
| 28 |
Ivana Milosevic, Nevena Todorovic, Ana Filipovic, Jelena Simic, Marko Markovic, Olja Stevanovic, Jovan Malinic, Natasa Katanic, Nikola Mitrovic, Natasa Nikolic. HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article. International Journal of Molecular Sciences 2023; 24(22) doi: 10.3390/ijms242216048
|
| 29 |
Pan Jiang, Chaoqi Xu, Ming Zhou, Huaqun Zhou, Weida Dong, Xiaoyue Wu, Aochang Chen, Qing Feng. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC). Carcinogenesis 2018; 39(2) doi: 10.1093/carcin/bgx138
|
| 30 |
Chrystelle L Vilfranc, Li-Xiao Che, Krushna C Patra, Liang Niu, Olugbenga Olowokure, Jiang Wang, Shimul A Shah, Chun-Ying Du. BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis. World Journal of Hepatology 2021; 13(3): 343-361 doi: 10.4254/wjh.v13.i3.343
|
| 31 |
Minjie Lin, Mengying Zhu, Tingqiu Ge, Naiying Lu, Xiling Fu, Jiabao Chang. Prognostic potential and mechanism of SORT1 and its co‐expressed genes in hepatocellular carcinoma based on integrative analysis of multiple database. Precision Medical Sciences 2022; 11(4) doi: 10.1002/prm2.12084
|
| 32 |
Ying Long, Miaolong Lu, Tingting Cheng, Xiaohan Zhan, Xianquan Zhan. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00835
|
| 33 |
Xinglong Qu, Ying Tang, Shucheng Hua. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00563
|
| 34 |
Raluca-Margit Szilveszter, Mara Muntean, Adrian Florea. Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview. Biomolecules 2024; 14(6) doi: 10.3390/biom14060656
|
| 35 |
Prashant R. Murumkar, Kaushik Neogi, Premlal Meher, Rasana Yadav, Karan Joshi, Omkumar Prajapati, Priyanshu Sharma, Poonam Yadav, Devarajan Karunagaran, Prasanta Kumar Nayak, Mange Ram Yadav.
Design and development of 2,7-disubstituted 6-methoxyquinazolin-4 (3
H
)-ones as potential anti-cancer agents possibly through downregulation of Wnt/β-catenin/TCF4 signaling pathway
. Future Medicinal Chemistry 2026; 18(17) doi: 10.1080/17568919.2026.2714576
|
| 36 |
Amit Kumar Singh, Shiv Vardan Singh, Ramesh Kumar, Shashank Kumar, Sabyasachi Senapati, Abhay K Pandey. Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise . World Journal of Hepatology 2023; 15(1): 1-18 doi: 10.4254/wjh.v15.i1.1
|
| 37 |
Mohammad Jaber MasodKhooy, Massoumeh Farasat, Mohamadreza Salehi Salmi, Hamed Mirzaei. Combinatorial treatment with Silybum marianum essential oil enhances the therapeutic efficacy of a 5‐fluorouracil base therapy for hepatocellular carcinoma. Phytotherapy Research 2023; 37(5) doi: 10.1002/ptr.7716
|
| 38 |
Federico Selvaggi, Teresa Catalano, Rossano Lattanzio, Roberto Cotellese, Gitana Maria Aceto. Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities. World Journal of Gastroenterology 2023; 29(18): 2764-2783 doi: 10.3748/wjg.v29.i18.2764
|
| 39 |
Longqin Li, Yichao Zheng, Qi Zheng, Jiaji Jiang. Mechanism of inhibiting proliferation of hepatocellular carcinoma Hepa1‑6 cells by embryonic stem cell‑conditioned medium. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8527
|
| 40 |
Alexandru Madalin Hasan, Ioana Larisa Paul, Simona Cavalu, Ovidiu Laurean Pop, Lorena Paduraru, Ioan Magyar, Mihaela Doina Chirila. Highlighting the Importance of Signaling Pathways and Immunohistochemistry Features in HCC: A Case Report and Literature Review. Reports 2025; 8(4) doi: 10.3390/reports8040197
|
| 41 |
Li-Juan Liu, Zhao Lv, Xing Xue, Zhong-Yuan Xing, Fan Zhu. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy. Cancers 2022; 14(23) doi: 10.3390/cancers14235781
|
| 42 |
Adewale Oluwaseun Fadaka, Ashwil Klein, Ashley Pretorius. In silico identification of microRNAs as candidate colorectal cancer biomarkers. Tumor Biology 2019; 41(11) doi: 10.1177/1010428319883721
|
| 43 |
Federico Selvaggi, Teresa Catalano, Roberto Cotellese, Gitana Maria Aceto. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents. Cancers 2022; 14(8) doi: 10.3390/cancers14081912
|
| 44 |
Jaime Arellanes-Robledo, Karina Reyes-Gordillo, Joseph Ibrahim, Leslie Leckey, Ruchi Shah, M. Raj Lakshman. Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro. Biochemical Pharmacology 2018; 156 doi: 10.1016/j.bcp.2018.08.021
|
| 45 |
Jing Zhan, Liang-liang Shi, Yan Wang, Bai Wei, Sheng-li Yang. In Vivo Study on the Effects of Xiaoaiping on the Stemness of Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2019; 2019 doi: 10.1155/2019/4738243
|
| 46 |
Chunmei Guo, Chao Gao, Dongting Zhao, Jiahui Li, Jinxia Wang, Xujuan Sun, Qinlong Liu, Lihong Hao, Frederick T. Greenaway, Yuxiang Tian, Shuqing Liu, Ming-Zhong Sun. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01559-1
|
| 47 |
Maryam Navaeian, Hossein Ahmadpour-Yazdi, Samieh Asadian, Nematollah Gheibi. The effect of ANGPTL8 protein on proliferation and apoptosis in HepG2 hepatocellular carcinoma cell line. Gene Reports 2021; 25 doi: 10.1016/j.genrep.2021.101306
|
| 48 |
Kristy Chan, Regina Lo. Deregulation of Frizzled Receptors in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(1) doi: 10.3390/ijms19010313
|
| 49 |
Essam Al Ageeli. Dual Roles of microRNA-122 in Hepatocellular Carcinoma and Breast Cancer Progression and Metastasis: A Comprehensive Review. Current Issues in Molecular Biology 2024; 46(11) doi: 10.3390/cimb46110711
|
| 50 |
Elisavet Lioulia, Panagiotis Mokos, Emmanuel Panteris, Dimitra Dafou. UBE2T promotes β‐catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK‐dependent activation. Molecular Oncology 2022; 16(8) doi: 10.1002/1878-0261.13111
|
| 51 |
Shuai He, Shilei Tang. WNT/β-catenin signaling in the development of liver cancers. Biomedicine & Pharmacotherapy 2020; 132 doi: 10.1016/j.biopha.2020.110851
|
| 52 |
Hung-Wen Tsai, Shu-Wen Cheng, Chou-Cheng Chen, I-Wen Chen, Chung-Liang Ho. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10655-2
|
| 53 |
Yara A. Samra, Al Shaima G. Abd El Salam, Amr M. Abdelghany, Mamdouh M. El-Shishtawy. Safranal-loaded gold nanoparticles alleviate hepatocellular carcinoma via targeting the Wnt/β-catenin pathway. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02447-w
|
| 54 |
Jude Tetteh Quarshie, Kwadwo Fosu, Nicholas Awuku Offei, Augustine Kojo Sobo, Osbourne Quaye, Anastasia Rosebud Aikins. Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling. Pharmaceuticals 2023; 16(7) doi: 10.3390/ph16071026
|
| 55 |
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, Reza Fathazam, Negin Rabiei, Haleh Piroozmand, Massoud Vosough, Neda Rahimian, Michael R. Hamblin, Hamed Mirzaei. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy - Nucleic Acids 2021; 26 doi: 10.1016/j.omtn.2021.10.004
|
| 56 |
Rabiatul Basria S. M. N. Mydin, Adam Azlan, Simon I. Okekpa, Nigel J. Gooderham. Regulatory role of miRNAs in nasopharyngeal cancer involving PTEN/PI3K/AKT, TGFβ/SMAD, RAS/MAPK, Wnt/β‐catenin and pRB‐E2F signaling pathways: A review. Cell Biochemistry and Function 2024; 42(2) doi: 10.1002/cbf.3945
|
| 57 |
Nur Rahadiani, Ignasia Andhini Retnowulan, Marini Stephanie, Diah Rini Handjari, Ening Krisnuhoni. β-Catenin Expression and Its Association with Prognostic Factors in Hepatocellular Carcinoma: A Study on Alpha-fetoprotein, Histologic Grade, and Microvascular Invasion. Open Access Macedonian Journal of Medical Sciences 2021; 9(A) doi: 10.3889/oamjms.2021.6123
|
| 58 |
Darshan Mehta, Akshay Paradkar, Bharat Rekhi, Prakash Nayak, Bhabani Mohanty, Pradip Chaudhari, Poonam Gera, Swapnil Rane, Pankaj Chaturvedi, Sanjeev K. Waghmare. Histone methylation defines c-Jun/Sox2/Hif1α axis that controls stemness and tumor progression in squamous cell carcinoma. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-71996-7
|
| 59 |
Xiaowen Mao, Sze Keong Tey, Frankie Chi Fat Ko, Ernest Man Lok Kwong, Yi Gao, Irene Oi-Lin Ng, Siu Tim Cheung, Xin-Yuan Guan, Judy Wai Ping Yam. C-terminal truncated HBx protein activates caveolin-1/LRP6/β-catenin/FRMD5 axis in promoting hepatocarcinogenesis. Cancer Letters 2019; 444 doi: 10.1016/j.canlet.2018.12.003
|
| 60 |
Melek Pehlivan, Ceyda Caliskan, Zeynep Yuce, Hakki O. Sercan. sFRP1 Expression Regulates Wnt Signaling in Chronic Myeloid Leukemia K562 Cells. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(7) doi: 10.2174/1871520621666210524162145
|
| 61 |
Michael H Kagey, Xi He. Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology. British Journal of Pharmacology 2017; 174(24) doi: 10.1111/bph.13894
|
| 62 |
Rainbow Wing Hei Leung, Terence Kin Wah Lee. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2022; 14(21) doi: 10.3390/cancers14215468
|
| 63 |
Yagmur Azbazdar, Yeliz Demirci, Guillaume Heger, Dogac Ipekgil, Mustafa Karabicici, Gunes Ozhan. Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β‐catenin signaling and tumor growth. Molecular Oncology 2023; 17(11) doi: 10.1002/1878-0261.13520
|
| 64 |
Meetu Rathee, Sheikh Mohammad Umar, Arundhathi J.R. Dev, Akanksha Kashyap, Sandeep R. Mathur, Ajay Gogia, Purusottam Mohapatra, Chandra Prakash Prasad. Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09694-0
|
| 65 |
Kyle M. Schachtschneider, Luke N. Redlon, Ryan Peter Lokken, Yu-Hui Huang, Grace Guzman, Lawrence B. Schook, Ron C. Gaba, Sripathi M Sureban. Epigenetic regulation of individual components of combined hepatocellular-cholangiocarcinoma. PLOS One 2025; 20(5) doi: 10.1371/journal.pone.0324145
|
| 66 |
Caihao Qu, Tengda Ma, Xin YAN, Xiaomei Li, Yumin Li. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma. Mathematical Biosciences and Engineering 2022; 19(3) doi: 10.3934/mbe.2022142
|
| 67 |
I. F. Kustova, A. S. Makarova, N. L. Lazarevich. Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsy. Advances in Molecular Oncology 2019; 5(4) doi: 10.17650/2313-805X-2018-5-4-8-19
|
| 68 |
Büşra Candan Balkan, Alper Demirezen, Oytun Erbaş. Genetic mapping of hair loss through the APCDD1 gene pathway: A new perspective. Demiroglu Science University Florence Nightingale Journal of Medicine 2024; 10(1) doi: 10.5606/fng.btd.2024.146
|
| 69 |
Katarzyna Kempinska, Bhavna Malik, Dmitry Borkin, Szymon Klossowski, Shirish Shukla, Hongzhi Miao, Jingya Wang, Tomasz Cierpicki, Jolanta Grembecka. Pharmacologic Inhibition of the Menin–MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2018; 17(1) doi: 10.1158/1535-7163.MCT-17-0580
|
| 70 |
Targeting Signaling Pathways in Solid Tumors - Part A. International Review of Cell and Molecular Biology 2024; 385 doi: 10.1016/bs.ircmb.2023.11.006
|
| 71 |
Simone Brivio, Massimiliano Cadamuro, Mario Strazzabosco, Luca Fabris. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. World Journal of Hepatology 2017; 9(9): 455-468 doi: 10.4254/wjh.v9.i9.455
|
| 72 |
Yi-Ming Chang, Po-Chun Chen, Chien-Peng Hsu, Peng-Fang Ma, Huey-Ling Chen, Shu-Hao Hsu. Loss of hepatic miR-194 promotes liver regeneration and protects from acetaminophen-induced acute liver injury. Biochemical Pharmacology 2022; 195 doi: 10.1016/j.bcp.2021.114862
|
| 73 |
Kuntan Wu, Minjie Liu, Huanbin Wang, Shahid Ali Rajput, Omar Mahmoud Al Zoubi, Shuai Wang, Desheng Qi. Effect of zearalenone on aflatoxin B1-induced intestinal and ovarian toxicity in pregnant and lactating rats. Ecotoxicology and Environmental Safety 2023; 258 doi: 10.1016/j.ecoenv.2023.114976
|
| 74 |
Yangyang Hu, Chao Deng, He Zhang, Jing Zhang, Bo Peng, Chuanyi Hu. Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer. Oncotarget 2017; 8(55) doi: 10.18632/oncotarget.21791
|
| 75 |
Zhengyao Xie, Zhiyan Dai, Ziyao Liu, Yiqiang Chen, Shuting Huang, Siyuan Liu, Jingjing Li, Jie Shen. The impact of an RNA-binding protein group on regulating the RSPO-LGR4/5-ZNRF3/RNF43 module and the immune microenvironment in hepatocellular carcinoma. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13874-x
|
| 76 |
M. Pehlivan, M. Soyoz, B. Cerci, H. I. K. Coven, Z. Yuce, H. O. Sercan. sFRP1 Expression Induces miRNAs That Modulate Wnt Signaling in Chronic Myeloid Leukemia Cells. Molecular Biology 2020; 54(4) doi: 10.1134/S0026893320040135
|
| 77 |
Dilip K. Patel, Roohi Kesharwani, Amita Verma, Fahad A. Al-Abbasi, Firoz Anwar, Vikas Kumar. Scope of Wnt signaling in the precise diagnosis and treatment of breast cancer. Drug Discovery Today 2023; 28(7) doi: 10.1016/j.drudis.2023.103597
|
| 78 |
Fereshteh Barjesteh, Nafiseh Heidari-Kalvani, Iraj Alipourfard, Mohammad Najafi, Elham Bahreini. Testosterone, β-estradiol, and hepatocellular carcinoma: stimulation or inhibition? A comparative effect analysis on cell cycle, apoptosis, and Wnt signaling of HepG2 cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(8) doi: 10.1007/s00210-024-03019-5
|
| 79 |
Al Shaima G. Abd El Salam, Yara A. Samra, Mamdouh M. El-Shishtawy. Cinnamaldehyde Relieves Induced Hepatocellular Carcinoma in Rat Model via Targeting Wnt/β-Catenin Pathway. Scientia Pharmaceutica 2022; 90(2) doi: 10.3390/scipharm90020022
|
| 80 |
Melek Pehlivan, Ceyda Çalışkan, Zeynep Yüce, Hakki Ogun Sercan. Secreted Wnt antagonists in leukemia: A road yet to be paved. Leukemia Research 2018; 69 doi: 10.1016/j.leukres.2018.03.011
|